Polycystic Ovarian Syndrome Treatment Market Global Report 2020-30

7609
Pages: 200
April 2020
Total Views:1546
Region : Global
The Business Research Company
Market Research Report

Bundle Purchase

Select a License

Single User License

USD 4000

Hard Copy License

USD 4000

Site License

USD 6000

CD-Rom

USD 4000

Corporate User License

USD 8000

Details

The polycystic ovarian syndrome treatment market consists of sale of services and related products that are used in hospital pharmacies, drug stores, and retail pharmacies to treat polycystic ovarian syndrome. The polycystic ovarian syndrome is a disorder in which hormones are out of control for females and have male hormones that are higher than normal, which causes them to skip menstrual periods and makes pregnancy more difficult for them.

The global polycystic ovarian syndrome treatment market was worth USD 3.83 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 5.00% and reach USD 4.65 billion by 2023.

The polycystic ovarian syndrome treatment market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. North America was the largest region .

The polycystic ovarian syndrome treatment market covered in this report is segmented by drug type into oral contraceptives, ornithine decarboxylase inhibitors, insulin-sensitizing agents, anti-depressants, diuretics, aromatase inhibitors. It is also segmented by surgery type into ovarian wedge resection and laparoscopic ovarian drilling.

The global rise in genetic and hormonal disorders is a key factor driving the growth of the polycystic ovarian syndrome (PCOS) treatment market. PCOS is a prevalent hormonal disorder among premenopausal women worldwide, with reproductive, endocrine, and metabolic abnormalities. The PCOS prevalence ranges from 2.2% to 26% globally and is highly variable. In China, the figures range between 2% to 7.5%, and 6.3% in Sri Lanka, 9.13% in in south India and 22.5% in Maharashtra. The rise in genetic and hormonal disorders globally is expected to increase the growth of the polycystic ovarian syndrome treatment market.

Lack of drugs approved by regulatory bodies such as FDA (Food and Drug Administration) among many countries is a key factor hampering the growth of the polycystic ovarian syndrome treatment market. FDA has not approved pharmacological treatment for use in adolescents with PCOS. However, some pharmacological interventions are used to treat PCOS symptoms. In 2017, FDA removed sibutramine (a sympathomimetic core appetite suppressant) from the US market due to concerns about increased Cardiovascular disease (CVD) events with its use. Additionally, rimonabant, a key appetite suppressant cannabinoid CB1 receptor antagonist was not approved in the USA due to concerns about suicidal ideation and drug overdoses. Therefore, the lack of regulatory body approved drugs in many countries is a key factor restraining the growth of the polycystic ovarian syndrome treatment market.

Laparoscopic ovarian drilling is a major trend driving the growth of the polycystic ovarian syndrome treatment market. Laparoscopic ovarian drilling is a surgical treatment performed by the doctors in critical conditions that can cause ovulation in women with polycystic ovary syndrome (PCOS). Ovarian drilling is often used by women with PCOS who often do not ovulate despite having attempted weight loss and use of fertility drugs. According to the study published in 2019 by the Department of Gynecology and Obstetrics in major hospitals in France, after laparoscopic drilling, 47.4% (137 patients) had pregnancy and 51.8% (71 patients) of these were spontaneous. 16.6% (48 patients) women had at least two pregnancies after drilling and 56.3% (27 patients) of these were spontaneous. 33 women received second drillings. Of these, 57.6% (19 patients) achieved at least one pregnancy, within this 52.6% (10 patients) were spontaneous.

In July 2019, Eurolife Healthcare Pvt. Ltd, a Mumbai based company, manufactures and distributes an exclusive portfolio of healthcare formulations, Intravenous Infusions, Ophthalmic, Sterilized water for Injections, Nebules, Tablets, Capsules, Ointment & Creams, acquired Teva Pharmaceutical Industries Ltd. for an undisclosed amount. This acquisition helped the company to tap and service its European and the US markets for intravenous infusions in a better way. Teva Pharmaceutical Industries Ltd., a multinational pharmaceutical company, develops, manufactures, and markets generic and branded human pharmaceuticals, as well as active pharmaceutical ingredients.

Major players in the market are Bristol-Myer Squibb Company, Bayer AG, Pfizer, Inc., Merck KGaA, Sanofi, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries Limited, Abbott and Addex Therapeutics Ltd.

Scope

1. Executive Summary

2. Polycystic Ovarian Syndrome Treatment Market Characteristics

3. Polycystic Ovarian Syndrome Treatment Market Size And Growth

3.1. Global Polycystic Ovarian Syndrome Treatment Historic Market, 2015-2019, USD Billion

3.1.1. Drivers Of The Market

3.1.2. Restraints On The Market

3.2. Global Polycystic Ovarian Syndrome Treatment Forecast Market, 2019-2023F, 2025F, 2030F, USD Billion

3.2.1. Drivers Of The Market

3.2.2. Restraints On the Market

4. Polycystic Ovarian Syndrome Treatment Market Segmentation

4.1. Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Oral Contraceptives

Ornithine Decarboxylase Inhibitors

Insulin-Sensitizing Agents

Anti-Depressants

Diuretics

Aromatase Inhibitors

4.2. Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By Surgery Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Ovarian Wedge Resection

Laparoscopic Ovarian Drilling

5. Polycystic Ovarian Syndrome Treatment Market Regional And Country Analysis

5.1. Global Polycystic Ovarian Syndrome Treatment Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

5.2. Global Polycystic Ovarian Syndrome Treatment Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

6. Asia-Pacific Polycystic Ovarian Syndrome Treatment Market

6.1. Asia-Pacific Polycystic Ovarian Syndrome Treatment Market Overview

6.2. Asia-Pacific Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

7. China Polycystic Ovarian Syndrome Treatment Market

7.1. China Polycystic Ovarian Syndrome Treatment Market Overview

7.2. China Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,USD Billion

8. India Polycystic Ovarian Syndrome Treatment Market

8.1. India Polycystic Ovarian Syndrome Treatment Market Overview

8.2. India Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

9. Japan Polycystic Ovarian Syndrome Treatment Market

9.1. Japan Polycystic Ovarian Syndrome Treatment Market Overview

9.2. Japan Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

10. Australia Polycystic Ovarian Syndrome Treatment Market

10.1. Australia Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

11. Indonesia Polycystic Ovarian Syndrome Treatment Market

11.1. Indonesia Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

12. South Korea Polycystic Ovarian Syndrome Treatment Market

12.1. South Korea Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

13. Western Europe Polycystic Ovarian Syndrome Treatment Market

13.1. Western Europe Polycystic Ovarian Syndrome Treatment Market Overview

13.2. Western Europe Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

14. UK Polycystic Ovarian Syndrome Treatment Market

14.1. UK Polycystic Ovarian Syndrome Treatment Market Overview

14.2. UK Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

15. Germany Polycystic Ovarian Syndrome Treatment Market

15.1. Germany Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

16. France Polycystic Ovarian Syndrome Treatment Market

16.3. France Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

17. Eastern Europe Polycystic Ovarian Syndrome Treatment Market

17.1. Eastern Europe Polycystic Ovarian Syndrome Treatment Market Overview

17.2. Eastern Europe Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

18. Russia Polycystic Ovarian Syndrome Treatment Market

18.1. Russia Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

19. North America Polycystic Ovarian Syndrome Treatment Market

19.1. North America Polycystic Ovarian Syndrome Treatment Market Overview

19.2. North America Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

20. USA Polycystic Ovarian Syndrome Treatment Market

20.1. USA Polycystic Ovarian Syndrome Treatment Market Overview

20.2. USA Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

21. South America Polycystic Ovarian Syndrome Treatment Market

21.1. South America Polycystic Ovarian Syndrome Treatment Market Overview

21.2. South America Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

22. Brazil Polycystic Ovarian Syndrome Treatment Market

22.1. Brazil Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

23. Middle East Polycystic Ovarian Syndrome Treatment Market

23.1. Middle East Polycystic Ovarian Syndrome Treatment Market Overview

23.2. Middle East Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

24. Africa Polycystic Ovarian Syndrome Treatment Market

24.1. Africa Polycystic Ovarian Syndrome Treatment Market Overview

24.2. Africa Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

25. Polycystic Ovarian Syndrome Treatment Market Competitive Landscape And Company Profiles

25.1. Polycystic Ovarian Syndrome Treatment Market Competitive Landscape

25.2. Polycystic Ovarian Syndrome Treatment Market Company Profiles

25.2.1. Bristol-Myer Squibb Company

25.2.1.1. Overview

25.2.1.2. Products and Services

25.2.1.3. Strategy

25.2.1.4. Financial Performance

25.2.2. Bayer AG

25.2.2.1. Overview

25.2.2.2. Products and Services

25.2.2.3. Strategy

25.2.2.4. Financial Performance

25.2.3. Pfizer, Inc.

25.2.3.1. Overview

25.2.3.2. Products and Services

25.2.3.3. Strategy

25.2.3.4. Financial Performance

25.2.4. Merck KGaA

25.2.4.1. Overview

25.2.4.2. Products and Services

25.2.4.3. Strategy

25.2.4.4. Financial Performance

25.2.5. Sanofi

25.2.5.1. Overview

25.2.5.2. Products and Services

25.2.5.3. Strategy

25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Polycystic Ovarian Syndrome Treatment Market

27. Polycystic Ovarian Syndrome Treatment Market Trends And Strategies

28. Polycystic Ovarian Syndrome Treatment Market Future Outlook and Potential Analysis

29. Appendix

29.1. Abbreviations

29.2. Currencies

29.3. Research Inquiries

29.4. The Business Research Company

29.5. Copyright And Disclaimer

List Of Figure

Figure 1: Global Historic Market Growth, 2015-2019, USD Billion

Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 3: Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 4: Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By Surgery Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 5: Global Polycystic Ovarian Syndrome Treatment Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 6: Global Polycystic Ovarian Syndrome Treatment Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 7: Asia-Pacific, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 8: China, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 9: India, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 10: Japan, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 11: Australia, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 12: Indonesia, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 13: South Korea, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 14: Western Europe, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 15: UK, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 16: Germany, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 17: France, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 18: Eastern Europe, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 19: Russia, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 20: North America, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 21: USA, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 22: South America, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 23: Brazil, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 24: Middle East, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 25: Africa, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Figure 26: Bristol-Myer Squibb Company Financial Performance

Figure 27: Bayer AG Financial Performance

Figure 28: Pfizer, Inc. Financial Performance

Figure 29: Merck KGaA Financial Performance

Figure 30: Sanofi Financial Performance

List Of Table

Table 1: Global Historic Market Growth, 2015-2019, USD Billion

Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 3: Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 4: Global Polycystic Ovarian Syndrome Treatment Market, Segmentation By Surgery Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 5: Global Polycystic Ovarian Syndrome Treatment Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 6: Global Polycystic Ovarian Syndrome Treatment Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 7: Asia-Pacific, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 8: China, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 9: India, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 10: Japan, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 11: Australia, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 12: Indonesia, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 13: South Korea, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 14: Western Europe, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 15: UK, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 16: Germany, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 17: France, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 18: Eastern Europe, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 19: Russia, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 20: North America, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 21: USA, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 22: South America, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 23: Brazil, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 24: Middle East, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 25: Africa, Polycystic Ovarian Syndrome Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, USD Billion

Table 26: Bristol-Myer Squibb Company Financial Performance

Table 27: Bayer AG Financial Performance

Table 28: Pfizer, Inc. Financial Performance

Table 29: Merck KGaA Financial Performance

Table 30: Sanofi Financial Performance

Licence Rights

Single User License (for access by one person)
Site License (for access of one office location of a company)
Corporate License (allow access by all staff of the company)

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

1) By Drug Type: Oral Contraceptives; Ornithine Decarboxylase Inhibitors; Insulin-Sensitizing Agents; Anti-Depressants; Diuretics; Aromatase Inhibitors; 2) By Surgery Type: Ovarian Wedge Resection; Laparoscopic Ovarian Drilling

Companies

Bristol-Myer Squibb Company; Bayer AG; Pfizer, Inc.; Merck KGaA; Sanofi; AstraZeneca; Novartis AG; Teva Pharmaceutical Industries Limited; Abbott; Addex Therapeutics Ltd; BIOCAD; Allergan plc.; Johnson and Johnson; Ferring BV; Ferring Pharmaceuticals, Inc.

Company Profile

Company Profile Title

Single User Licence

USD 200

Corporate User Licence

USD 500